Home › Funds › SECTORAL ASSET MANAGEMENT INC › CBIO
SECTORAL ASSET MANAGEMENT INC position in CBIO
CRESCENT BIOPHARMA INC. · Health Care
SECTORAL ASSET MANAGEMENT INC reported holding 167,600 shares of CBIO (CRESCENT BIOPHARMA INC.) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 1.82% of its reported portfolio and ranking #22 among its reported holdings. SECTORAL ASSET MANAGEMENT INC has disclosed CBIO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SECTORAL ASSET MANAGEMENT INC's CBIO position evolved
SECTORAL ASSET MANAGEMENT INC first disclosed a stake in CBIO in Q2 2026 at 121,300 shares (US$2.2M). The position peaked in Q3 2026 at 167,600 shares, worth US$2.4M. Across 2 filings, SECTORAL ASSET MANAGEMENT INC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 167,600 shares valued at US$2.4M — an increase of 46,300 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 121.30K | $2.18M | New |
| Q3 2026 | 167.60K | $2.45M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CBIO and 13F data
CBIO (CRESCENT BIOPHARMA INC.) is a Health Care company. 69 other funds we track also report a position in CBIO — the largest reported positions include BVF INC/IL (US$49.5M), Fairmount Funds Management LLC (US$49.5M), Venrock Adviser, LLC (US$38.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CBIO
- BVF INC/IL 2.75M sh · $49.48M · Q2 2026
- Fairmount Funds Management LLC 2.75M sh · $49.46M · Q2 2026
- Venrock Adviser, LLC 2.13M sh · $38.40M · Q2 2026
- Logos Global Management LP 1.90M sh · $34.20M · Q2 2026
- FCPM III SERVICES B.V. 1.68M sh · $30.20M · Q2 2026
- Vestal Point Capital, LP 1.63M sh · $29.34M · Q2 2026
- Opaleye Management Inc. 1.32M sh · $23.75M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.16M sh · $20.88M · Q2 2026
- Boxer Capital Management, LLC 453.69K sh · $8.17M · Q2 2026
- NEXTBio Capital Management LP 372.86K sh · $5.44M · Q3 2026
- Remedium Capital Partners, LLC 361.25K sh · $5.27M · Q3 2026
- STEMPOINT CAPITAL LP 182.38K sh · $3.28M · Q2 2026
More on SECTORAL ASSET MANAGEMENT INC
FAQ
How long has SECTORAL ASSET MANAGEMENT INC held CBIO?
SECTORAL ASSET MANAGEMENT INC has disclosed CBIO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is SECTORAL ASSET MANAGEMENT INC's current position in CBIO?
As of Q3 2026, SECTORAL ASSET MANAGEMENT INC holds 167.60K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $2.45M, representing 1.82% of its reported portfolio and ranking #22.
Has SECTORAL ASSET MANAGEMENT INC been buying or selling CBIO?
In the latest 13F filing (Q3 2026), SECTORAL ASSET MANAGEMENT INC increased its position in CBIO. The position peaked in Q3 2026 at 167.60K shares.
Which other funds hold CBIO?
Other major institutional holders of CBIO include BVF INC/IL, Fairmount Funds Management LLC, Venrock Adviser, LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.